Nipah Virus mRNA Vaccine: Phase 1 Trial Results
Promising Nipah Virus Vaccine Shows Sustained Immune Response in Early Trials In a significant step forward in the fight against the deadly Nipah virus, a novel mRNA vaccine has demonstrated both safety and a robust immune response lasting up to one year in healthy adult volunteers. The findings, stemming from a phase 1 clinical trial, … Read more